| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prolactin receptor binding | 1.66e-09 | 7 | 54 | 4 | GO:0005148 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 9.91e-09 | 10 | 54 | 4 | GO:0005131 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 2.09e-06 | 34 | 54 | 4 | GO:0051427 | |
| GeneOntologyMolecularFunction | hormone activity | 3.18e-05 | 135 | 54 | 5 | GO:0005179 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 3.15e-04 | 49 | 54 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | TAP1 binding | 3.19e-04 | 10 | 54 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 3.19e-04 | 10 | 54 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 3.19e-04 | 10 | 54 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | growth factor activity | 1.23e-03 | 173 | 54 | 4 | GO:0008083 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid hormone biosynthetic process | 2.73e-08 | 13 | 53 | 4 | GO:0090031 | |
| GeneOntologyBiologicalProcess | regulation of response to nutrient levels | 1.17e-07 | 46 | 53 | 5 | GO:0032107 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone biosynthetic process | 1.46e-07 | 19 | 53 | 4 | GO:0046886 | |
| GeneOntologyBiologicalProcess | response to food | 3.82e-07 | 58 | 53 | 5 | GO:0032094 | |
| GeneOntologyBiologicalProcess | regulation of steroid hormone biosynthetic process | 3.97e-07 | 24 | 53 | 4 | GO:0090030 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 5.57e-07 | 26 | 53 | 4 | GO:0060396 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone metabolic process | 5.57e-07 | 26 | 53 | 4 | GO:0032352 | |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 6.52e-07 | 27 | 53 | 4 | GO:0071378 | |
| GeneOntologyBiologicalProcess | regulation of hormone biosynthetic process | 2.15e-06 | 36 | 53 | 4 | GO:0046885 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid biosynthetic process | 2.69e-06 | 38 | 53 | 4 | GO:0010893 | |
| GeneOntologyBiologicalProcess | response to growth hormone | 3.67e-06 | 41 | 53 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | positive regulation of steroid metabolic process | 4.04e-06 | 42 | 53 | 4 | GO:0045940 | |
| GeneOntologyBiologicalProcess | positive regulation of multicellular organism growth | 6.38e-06 | 47 | 53 | 4 | GO:0040018 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid biosynthetic process | 1.46e-05 | 121 | 53 | 5 | GO:0046889 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 1.49e-05 | 58 | 53 | 4 | GO:0046427 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 1.49e-05 | 58 | 53 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | positive regulation of D-glucose transmembrane transport | 2.07e-05 | 63 | 53 | 4 | GO:0010828 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via STAT | 2.34e-05 | 65 | 53 | 4 | GO:1904894 | |
| GeneOntologyBiologicalProcess | positive regulation of tyrosine phosphorylation of STAT protein | 2.97e-05 | 69 | 53 | 4 | GO:0042531 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle formation | 3.87e-05 | 4 | 53 | 2 | GO:0003218 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 4.13e-05 | 75 | 53 | 4 | GO:0048286 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 4.16e-05 | 249 | 53 | 6 | GO:0035264 | |
| GeneOntologyBiologicalProcess | hormone biosynthetic process | 6.14e-05 | 83 | 53 | 4 | GO:0042446 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid metabolic process | 6.49e-05 | 165 | 53 | 5 | GO:0045834 | |
| GeneOntologyBiologicalProcess | regulation of tyrosine phosphorylation of STAT protein | 6.74e-05 | 85 | 53 | 4 | GO:0042509 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 7.38e-05 | 87 | 53 | 4 | GO:0033143 | |
| GeneOntologyBiologicalProcess | tyrosine phosphorylation of STAT protein | 8.43e-05 | 90 | 53 | 4 | GO:0007260 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 8.96e-05 | 286 | 53 | 6 | GO:0042445 | |
| GeneOntologyBiologicalProcess | regulation of multicellular organism growth | 9.58e-05 | 93 | 53 | 4 | GO:0040014 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-tyrosine phosphorylation | 1.36e-04 | 193 | 53 | 5 | GO:0050731 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 1.48e-04 | 104 | 53 | 4 | GO:0007405 | |
| GeneOntologyBiologicalProcess | regulation of D-glucose transmembrane transport | 1.53e-04 | 105 | 53 | 4 | GO:0010827 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 1.59e-04 | 106 | 53 | 4 | GO:0050810 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 2.25e-04 | 46 | 53 | 3 | GO:0009303 | |
| GeneOntologyBiologicalProcess | protection from natural killer cell mediated cytotoxicity | 2.31e-04 | 9 | 53 | 2 | GO:0042270 | |
| GeneOntologyBiologicalProcess | response to radiation | 2.87e-04 | 503 | 53 | 7 | GO:0009314 | |
| GeneOntologyBiologicalProcess | cardiac ventricle formation | 2.88e-04 | 10 | 53 | 2 | GO:0003211 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 2.99e-04 | 125 | 53 | 4 | GO:0046425 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 3.33e-04 | 684 | 53 | 8 | GO:0010817 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 3.58e-04 | 238 | 53 | 5 | GO:0048639 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 4.01e-04 | 135 | 53 | 4 | GO:0019218 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 4.12e-04 | 136 | 53 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | regulation of lipid biosynthetic process | 4.17e-04 | 246 | 53 | 5 | GO:0046890 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 4.21e-04 | 381 | 53 | 6 | GO:0071375 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 4.27e-04 | 382 | 53 | 6 | GO:0009416 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 4.98e-04 | 143 | 53 | 4 | GO:1904892 | |
| GeneOntologyBiologicalProcess | D-glucose transmembrane transport | 5.67e-04 | 148 | 53 | 4 | GO:1904659 | |
| GeneOntologyBiologicalProcess | cardiac chamber formation | 5.78e-04 | 14 | 53 | 2 | GO:0003207 | |
| GeneOntologyBiologicalProcess | hexose transmembrane transport | 6.12e-04 | 151 | 53 | 4 | GO:0008645 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 6.47e-04 | 271 | 53 | 5 | GO:0032869 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-tyrosine phosphorylation | 6.58e-04 | 272 | 53 | 5 | GO:0050730 | |
| GeneOntologyBiologicalProcess | monosaccharide transmembrane transport | 6.58e-04 | 154 | 53 | 4 | GO:0015749 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 6.69e-04 | 273 | 53 | 5 | GO:0034764 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.75e-04 | 155 | 53 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | photoreceptor cell development | 8.78e-04 | 73 | 53 | 3 | GO:0042461 | |
| GeneOntologyBiologicalProcess | carbohydrate transmembrane transport | 9.11e-04 | 168 | 53 | 4 | GO:0034219 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.06e-03 | 78 | 53 | 3 | GO:0003170 | |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 1.10e-03 | 79 | 53 | 3 | GO:0006360 | |
| GeneOntologyBiologicalProcess | carbohydrate transport | 1.33e-03 | 186 | 53 | 4 | GO:0008643 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.35e-03 | 187 | 53 | 4 | GO:0007156 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine phosphorylation | 1.49e-03 | 327 | 53 | 5 | GO:0018108 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine modification | 1.54e-03 | 329 | 53 | 5 | GO:0018212 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.58e-03 | 23 | 53 | 2 | GO:0019885 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 1.67e-03 | 198 | 53 | 4 | GO:0007259 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 1.75e-03 | 339 | 53 | 5 | GO:0045927 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.80e-03 | 202 | 53 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | response to insulin | 1.82e-03 | 342 | 53 | 5 | GO:0032868 | |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 1.87e-03 | 25 | 53 | 2 | GO:0003214 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.87e-03 | 25 | 53 | 2 | GO:0002483 | |
| GeneOntologyBiologicalProcess | photoreceptor cell differentiation | 1.93e-03 | 96 | 53 | 3 | GO:0046530 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 2.00e-03 | 515 | 53 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | nucleolar large rRNA transcription by RNA polymerase I | 2.02e-03 | 26 | 53 | 2 | GO:0042790 | |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 2.03e-03 | 209 | 53 | 4 | GO:0006694 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 2.11e-03 | 354 | 53 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | developmental growth | 2.13e-03 | 911 | 53 | 8 | GO:0048589 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 2.29e-03 | 216 | 53 | 4 | GO:0097696 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 2.31e-03 | 530 | 53 | 6 | GO:0043434 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 5.94e-10 | 6 | 54 | 4 | GO:0070195 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.69e-05 | 443 | 54 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | trans-Golgi network | 1.34e-04 | 306 | 54 | 6 | GO:0005802 | |
| GeneOntologyCellularComponent | endosome lumen | 1.87e-04 | 43 | 54 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 5.84e-04 | 14 | 54 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 8.69e-04 | 17 | 54 | 2 | GO:0033106 | |
| MousePheno | decreased pituitary gland weight | 4.42e-09 | 8 | 41 | 4 | MP:0008938 | |
| MousePheno | absent somatotrophs | 7.94e-09 | 9 | 41 | 4 | MP:0008330 | |
| MousePheno | absent lactotrophs | 7.94e-09 | 9 | 41 | 4 | MP:0008333 | |
| MousePheno | increased circulating ghrelin level | 3.10e-08 | 12 | 41 | 4 | MP:0011612 | |
| MousePheno | abnormal pituitary gland weight | 3.10e-08 | 12 | 41 | 4 | MP:0008937 | |
| MousePheno | abnormal circulating ghrelin level | 8.49e-08 | 15 | 41 | 4 | MP:0011611 | |
| MousePheno | decreased lactotroph cell number | 1.47e-07 | 17 | 41 | 4 | MP:0008332 | |
| MousePheno | abnormal lactotroph morphology | 2.39e-07 | 19 | 41 | 4 | MP:0008323 | |
| MousePheno | delayed sexual maturation | 2.92e-07 | 49 | 41 | 5 | MP:0001938 | |
| MousePheno | decreased somatotroph cell number | 3.68e-07 | 21 | 41 | 4 | MP:0008329 | |
| MousePheno | small adenohypophysis | 5.42e-07 | 23 | 41 | 4 | MP:0008321 | |
| MousePheno | abnormal somatotroph morphology | 6.49e-07 | 24 | 41 | 4 | MP:0008322 | |
| MousePheno | delayed vaginal opening | 1.24e-06 | 28 | 41 | 4 | MP:0002636 | |
| MousePheno | small pituitary gland | 1.65e-06 | 30 | 41 | 4 | MP:0005361 | |
| MousePheno | abnormal timing of vaginal opening | 1.89e-06 | 31 | 41 | 4 | MP:0020150 | |
| MousePheno | abnormal sexual maturation | 2.34e-06 | 74 | 41 | 5 | MP:0001937 | |
| MousePheno | abnormal secondary sex determination | 6.17e-06 | 90 | 41 | 5 | MP:0002212 | |
| MousePheno | abnormal pituitary gland size | 6.58e-06 | 42 | 41 | 4 | MP:0008936 | |
| MousePheno | increased brown adipose tissue amount | 7.23e-06 | 43 | 41 | 4 | MP:0000005 | |
| MousePheno | increased white adipose tissue amount | 1.56e-05 | 52 | 41 | 4 | MP:0000008 | |
| MousePheno | disproportionate dwarf | 2.25e-05 | 57 | 41 | 4 | MP:0002427 | |
| MousePheno | decreased kidney weight | 4.02e-05 | 66 | 41 | 4 | MP:0003918 | |
| MousePheno | abnormal brown adipose tissue amount | 9.44e-05 | 82 | 41 | 4 | MP:0001778 | |
| MousePheno | abnormal adenohypophysis morphology | 1.48e-04 | 92 | 41 | 4 | MP:0004163 | |
| MousePheno | decreased lean body mass | 1.61e-04 | 407 | 41 | 7 | MP:0003961 | |
| MousePheno | female infertility | 1.68e-04 | 410 | 41 | 7 | MP:0001926 | |
| MousePheno | increased total body fat amount | 2.07e-04 | 424 | 41 | 7 | MP:0010024 | |
| MousePheno | decreased fasting circulating glucose level | 2.81e-04 | 200 | 41 | 5 | MP:0013278 | |
| MousePheno | aorta hypoplasia | 2.98e-04 | 9 | 41 | 2 | MP:0010541 | |
| MousePheno | decreased spleen weight | 3.26e-04 | 113 | 41 | 4 | MP:0004953 | |
| MousePheno | decreased prepulse inhibition | 3.58e-04 | 464 | 41 | 7 | MP:0009142 | |
| MousePheno | decreased bone mineral content | 3.63e-04 | 465 | 41 | 7 | MP:0010124 | |
| MousePheno | decreased heart weight | 3.84e-04 | 118 | 41 | 4 | MP:0002834 | |
| MousePheno | abnormal heart size | GH1 GH2 CSH1 CSH2 RTTN HLA-E LRRC10 PCDHA12 PCDHA10 CTSA BIRC6 | 4.37e-04 | 1180 | 41 | 11 | MP:0005406 |
| MousePheno | abnormal pituitary gland morphology | 6.39e-04 | 135 | 41 | 4 | MP:0000633 | |
| MousePheno | abnormal white adipose tissue amount | 6.94e-04 | 138 | 41 | 4 | MP:0001781 | |
| MousePheno | abnormal prepulse inhibition | 9.05e-04 | 542 | 41 | 7 | MP:0003088 | |
| MousePheno | abnormal brown adipose tissue morphology | 1.10e-03 | 156 | 41 | 4 | MP:0002971 | |
| MousePheno | abnormal neuroendocrine gland morphology | 1.10e-03 | 156 | 41 | 4 | MP:0000631 | |
| MousePheno | aorta stenosis | 1.11e-03 | 17 | 41 | 2 | MP:0010463 | |
| MousePheno | thrombocytopenia | 1.15e-03 | 273 | 41 | 5 | MP:0003179 | |
| MousePheno | small spleen | 1.25e-03 | 416 | 41 | 6 | MP:0000692 | |
| MousePheno | abnormal lean body mass | 1.29e-03 | 749 | 41 | 8 | MP:0003959 | |
| MousePheno | abnormal diencephalon morphology | 1.70e-03 | 298 | 41 | 5 | MP:0000830 | |
| MousePheno | abnormal CNS synaptic transmission | 1.86e-03 | 985 | 41 | 9 | MP:0002206 | |
| MousePheno | decreased skeletal muscle weight | 2.22e-03 | 24 | 41 | 2 | MP:0010239 | |
| MousePheno | small heart | 2.35e-03 | 321 | 41 | 5 | MP:0002188 | |
| MousePheno | bicuspid aortic valve | 2.41e-03 | 25 | 41 | 2 | MP:0010484 | |
| MousePheno | abnormal fasting circulating glucose level | 2.42e-03 | 474 | 41 | 6 | MP:0013277 | |
| Domain | SOMATOTROPIN_2 | 7.98e-10 | 6 | 52 | 4 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 7.98e-10 | 6 | 52 | 4 | PS00266 | |
| Domain | Hormone_1 | 7.98e-10 | 6 | 52 | 4 | PF00103 | |
| Domain | Somatotropin | 1.86e-09 | 7 | 52 | 4 | IPR001400 | |
| Domain | Somatotropin_CS | 2.03e-07 | 5 | 52 | 3 | IPR018116 | |
| Domain | Cadherin_tail | 3.30e-06 | 37 | 52 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 3.30e-06 | 37 | 52 | 4 | IPR031904 | |
| Domain | 4_helix_cytokine_core | 1.21e-05 | 51 | 52 | 4 | IPR012351 | |
| Domain | Cadherin_N | 3.19e-05 | 65 | 52 | 4 | IPR013164 | |
| Domain | Cadherin_2 | 3.19e-05 | 65 | 52 | 4 | PF08266 | |
| Domain | 4_helix_cytokine-like_core | 5.32e-05 | 74 | 52 | 4 | IPR009079 | |
| Domain | Cadherin_CS | 2.40e-04 | 109 | 52 | 4 | IPR020894 | |
| Domain | Cadherin | 2.75e-04 | 113 | 52 | 4 | PF00028 | |
| Domain | CADHERIN_1 | 2.75e-04 | 113 | 52 | 4 | PS00232 | |
| Domain | CADHERIN_2 | 2.84e-04 | 114 | 52 | 4 | PS50268 | |
| Domain | - | 2.84e-04 | 114 | 52 | 4 | 2.60.40.60 | |
| Domain | CA | 2.94e-04 | 115 | 52 | 4 | SM00112 | |
| Domain | Cadherin-like | 3.04e-04 | 116 | 52 | 4 | IPR015919 | |
| Domain | Cadherin | 3.24e-04 | 118 | 52 | 4 | IPR002126 | |
| Domain | - | 3.64e-04 | 50 | 52 | 3 | 1.20.1250.10 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.99e-08 | 13 | 34 | 4 | MM14516 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 5.03e-08 | 16 | 34 | 4 | MM15710 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 1.07e-07 | 19 | 34 | 4 | MM1513 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 1.33e-07 | 20 | 34 | 4 | MM15070 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 4.06e-07 | 26 | 34 | 4 | MM1345 | |
| Pathway | BIOCARTA_TFF_PATHWAY | 6.42e-07 | 29 | 34 | 4 | MM1522 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.10e-06 | 33 | 34 | 4 | MM1404 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 5.72e-06 | 15 | 34 | 3 | M552 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.04e-05 | 326 | 34 | 7 | MM15917 | |
| Pathway | WP_PI3KAKT_SIGNALING | 1.34e-05 | 339 | 34 | 7 | M39736 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_METABOLISM | 2.31e-05 | 70 | 34 | 4 | MM14916 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.51e-05 | 24 | 34 | 3 | M519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 4.03e-05 | 28 | 34 | 3 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 1.18e-04 | 7 | 34 | 2 | M47646 | |
| Pathway | WP_ADIPOGENESIS_GENES | 3.16e-04 | 137 | 34 | 4 | MM15970 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.67e-04 | 12 | 34 | 2 | M47529 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 7.51e-04 | 17 | 34 | 2 | M47905 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 8.43e-04 | 18 | 34 | 2 | MM14525 | |
| Pubmed | The rapid activation of protein synthesis by growth hormone requires signaling through mTOR. | 1.56e-13 | 7 | 54 | 5 | 17284572 | |
| Pubmed | microRNA-449a reduces growth hormone-stimulated senescent cell burden through PI3K-mTOR signaling. | 1.56e-13 | 7 | 54 | 5 | 36976763 | |
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 7169009 | ||
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 2.59e-11 | 5 | 54 | 4 | 31479305 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 10767558 | ||
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 2.59e-11 | 5 | 54 | 4 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 2.59e-11 | 5 | 54 | 4 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 2.59e-11 | 5 | 54 | 4 | 16508206 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 18006625 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 15616010 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 2.59e-11 | 5 | 54 | 4 | 32556100 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 2.59e-11 | 5 | 54 | 4 | 11346667 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 12010633 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 2.59e-11 | 5 | 54 | 4 | 17626886 | |
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 2.59e-11 | 5 | 54 | 4 | 24218587 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 19359380 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 2.59e-11 | 5 | 54 | 4 | 16201410 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 15316240 | ||
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 2.59e-11 | 5 | 54 | 4 | 11487592 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 11318985 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 2.59e-11 | 5 | 54 | 4 | 18203262 | |
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 2.59e-11 | 5 | 54 | 4 | 17272398 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 20707609 | ||
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 2.59e-11 | 5 | 54 | 4 | 2249485 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 17242167 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 18180319 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 1874564 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 2.59e-11 | 5 | 54 | 4 | 12225773 | |
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 2.59e-11 | 5 | 54 | 4 | 32100023 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 3780533 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 10395045 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 2.59e-11 | 5 | 54 | 4 | 8552145 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 2.59e-11 | 5 | 54 | 4 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 2.59e-11 | 5 | 54 | 4 | 8647448 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 26887678 | ||
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 2.59e-11 | 5 | 54 | 4 | 10810296 | |
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 2.59e-11 | 5 | 54 | 4 | 8756530 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 31099824 | ||
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 2.59e-11 | 5 | 54 | 4 | 7965203 | |
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 2.59e-11 | 5 | 54 | 4 | 1980158 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 2.59e-11 | 5 | 54 | 4 | 23861378 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 2.59e-11 | 5 | 54 | 4 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 2.59e-11 | 5 | 54 | 4 | 11350075 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 18617616 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 17347312 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 2.59e-11 | 5 | 54 | 4 | 10974531 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 21852148 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 12175649 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 15070902 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 23428905 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 2.59e-11 | 5 | 54 | 4 | 24758742 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 2.59e-11 | 5 | 54 | 4 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 2.59e-11 | 5 | 54 | 4 | 23639351 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 21098290 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 2.59e-11 | 5 | 54 | 4 | 17761891 | |
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 2.59e-11 | 5 | 54 | 4 | 18948397 | |
| Pubmed | The human growth hormone locus: nucleotide sequence, biology, and evolution. | 7.76e-11 | 6 | 54 | 4 | 2744760 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 12399427 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 14596666 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 7.76e-11 | 6 | 54 | 4 | 20032199 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 11316754 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 11309401 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 23150490 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 2991252 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 25017732 | ||
| Pubmed | Third party data gene data set of eutherian growth hormone genes. | 7.76e-11 | 6 | 54 | 4 | 26697363 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 10689811 | ||
| Pubmed | Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse. | 7.76e-11 | 6 | 54 | 4 | 15985453 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 20863500 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 24949662 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 33539533 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 20231469 | ||
| Pubmed | Growth hormone resistance: clinical states and animal models. | 7.76e-11 | 6 | 54 | 4 | 10556764 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 12208853 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 9175714 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 16141391 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 18618017 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 12166626 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 9275086 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 23782652 | ||
| Pubmed | Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. | 7.76e-11 | 6 | 54 | 4 | 14759511 | |
| Pubmed | Age related changes in gene expression within the cochlea of C57BL/6J mice. | 7.76e-11 | 6 | 54 | 4 | 23010755 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 25645493 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 15166120 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 24691732 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 21725989 | ||
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 38951485 | ||
| Pubmed | Evidence that growth hormone exerts a feedback effect on stomach ghrelin production and secretion. | 7.76e-11 | 6 | 54 | 4 | 14530511 | |
| Pubmed | Growth hormone controls lipolysis by regulation of FSP27 expression. | 7.76e-11 | 6 | 54 | 4 | 30400015 | |
| Interaction | PCDHA7 interactions | 3.87e-08 | 14 | 52 | 4 | int:PCDHA7 | |
| Interaction | PCDHA12 interactions | 1.19e-07 | 46 | 52 | 5 | int:PCDHA12 | |
| Interaction | PCDHA10 interactions | 2.78e-07 | 22 | 52 | 4 | int:PCDHA10 | |
| Interaction | CSH2 interactions | 7.21e-06 | 15 | 52 | 3 | int:CSH2 | |
| Interaction | GH1 interactions | 8.86e-06 | 16 | 52 | 3 | int:GH1 | |
| Interaction | PCDHA8 interactions | 1.22e-05 | 55 | 52 | 4 | int:PCDHA8 | |
| Interaction | CSH1 interactions | 1.29e-05 | 18 | 52 | 3 | int:CSH1 | |
| Interaction | CNNM1 interactions | 1.31e-05 | 56 | 52 | 4 | int:CNNM1 | |
| Interaction | PCDHA11 interactions | 1.52e-05 | 19 | 52 | 3 | int:PCDHA11 | |
| Interaction | PCDHGA10 interactions | 1.52e-05 | 19 | 52 | 3 | int:PCDHGA10 | |
| Interaction | PCDHA4 interactions | 1.73e-05 | 60 | 52 | 4 | int:PCDHA4 | |
| Interaction | PCDHA13 interactions | 1.36e-04 | 7 | 52 | 2 | int:PCDHA13 | |
| Interaction | CSHL1 interactions | 1.36e-04 | 7 | 52 | 2 | int:CSHL1 | |
| Interaction | APLNR interactions | 2.09e-04 | 211 | 52 | 5 | int:APLNR | |
| Interaction | PCDHA6 interactions | 2.32e-04 | 9 | 52 | 2 | int:PCDHA6 | |
| Interaction | PCDHA1 interactions | 2.32e-04 | 9 | 52 | 2 | int:PCDHA1 | |
| Interaction | TMEM39A interactions | 2.75e-04 | 49 | 52 | 3 | int:TMEM39A | |
| Interaction | MFSD4A interactions | 2.81e-04 | 225 | 52 | 5 | int:MFSD4A | |
| Cytoband | 17q24.2 | 4.58e-08 | 30 | 54 | 4 | 17q24.2 | |
| Cytoband | 5q31 | 1.07e-05 | 115 | 54 | 4 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 1.27e-05 | 120 | 54 | 4 | chr17q23 | |
| Cytoband | 10p12.33 | 3.79e-05 | 8 | 54 | 2 | 10p12.33 | |
| Cytoband | 20q13.1 | 6.07e-05 | 10 | 54 | 2 | 20q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 4.26e-04 | 298 | 54 | 4 | chr5q31 | |
| GeneFamily | Growth hormone family | 2.22e-10 | 6 | 37 | 4 | 1175 | |
| GeneFamily | Clustered protocadherins | 8.64e-06 | 64 | 37 | 4 | 20 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.39e-06 | 93 | 54 | 5 | M40279 | |
| Coexpression | WANG_LSD1_TARGETS_DN | 2.25e-06 | 45 | 54 | 4 | MM740 | |
| Coexpression | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN | 5.86e-06 | 57 | 54 | 4 | MM807 | |
| Coexpression | ZAMORA_NOS2_TARGETS_UP | 7.20e-06 | 60 | 54 | 4 | MM1165 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 1.66e-05 | 74 | 54 | 4 | MM769 | |
| Computational | Neighborhood of MMP11 | 1.35e-04 | 42 | 26 | 3 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.78e-04 | 46 | 26 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.15e-04 | 49 | 26 | 3 | GNF2_KISS1 | |
| Drug | alpha-bromoergocriptine | 1.07e-06 | 142 | 54 | 6 | CID000002443 | |
| Drug | Cabergoline-d5 | 1.57e-06 | 83 | 54 | 5 | CID000002512 | |
| Drug | 3'dGTP | 5.62e-06 | 15 | 54 | 3 | CID000148770 | |
| Drug | alpha-methylhomocysteine-thiolactone | 8.81e-06 | 55 | 54 | 4 | CID000133014 | |
| Drug | beta-carene | 1.65e-05 | 3 | 54 | 2 | CID000011129 | |
| Drug | prostaglandins G | 2.44e-05 | 71 | 54 | 4 | CID000078964 | |
| Drug | MK-677 | 2.72e-05 | 73 | 54 | 4 | CID000178024 | |
| Drug | T-E-A-T | 3.19e-05 | 76 | 54 | 4 | CID000086807 | |
| Drug | Zr-C | 3.30e-05 | 4 | 54 | 2 | CID000449163 | |
| Drug | C-S-S | 3.91e-05 | 80 | 54 | 4 | CID000165331 | |
| Drug | 4-benzyloxybutyric acid | 5.50e-05 | 5 | 54 | 2 | CID000562201 | |
| Drug | nopinone | 5.50e-05 | 5 | 54 | 2 | CID000032735 | |
| Drug | Bay P 8857 | 5.50e-05 | 5 | 54 | 2 | CID003086449 | |
| Drug | NSC9700 | 6.11e-05 | 578 | 54 | 8 | CID000005408 | |
| Drug | atrazine | 6.21e-05 | 90 | 54 | 4 | CID000002256 | |
| Drug | pyridostigmine | 7.06e-05 | 93 | 54 | 4 | CID000004991 | |
| Drug | GHRP-6 | 7.99e-05 | 96 | 54 | 4 | CID004345065 | |
| Drug | 2brn | 8.65e-05 | 98 | 54 | 4 | CID004369434 | |
| Drug | gadolinium | 1.08e-04 | 199 | 54 | 5 | CID000023982 | |
| Drug | AC1L947I | 1.15e-04 | 7 | 54 | 2 | CID000437680 | |
| Drug | C 15 | 1.15e-04 | 7 | 54 | 2 | CID003014700 | |
| Drug | 16-PC | 1.15e-04 | 7 | 54 | 2 | CID006454583 | |
| Drug | SureCN160413 | 1.17e-04 | 40 | 54 | 3 | CID011446521 | |
| Drug | hydroxylysine | 1.31e-04 | 109 | 54 | 4 | CID000001029 | |
| Drug | 2-(ethylsulfonyl)ethanol | 1.39e-04 | 210 | 54 | 5 | CID000010549 | |
| Drug | AC1L3OEQ | 1.53e-04 | 8 | 54 | 2 | CID000119216 | |
| Drug | GH 5 | 1.67e-04 | 45 | 54 | 3 | CID000163897 | |
| Drug | gly-pro | 1.83e-04 | 119 | 54 | 4 | CID000079101 | |
| Drug | boron monoxide | 1.95e-04 | 121 | 54 | 4 | CID006327189 | |
| Drug | 2,6-t | 1.97e-04 | 9 | 54 | 2 | CID000011331 | |
| Drug | I82-2 | 1.97e-04 | 9 | 54 | 2 | CID000007899 | |
| Drug | S2-o | 1.97e-04 | 9 | 54 | 2 | CID000140772 | |
| Drug | AC1O5E2B | 1.97e-04 | 9 | 54 | 2 | CID002724224 | |
| Drug | NSC20266 | 2.02e-04 | 122 | 54 | 4 | CID000000812 | |
| Drug | TRH-T | 2.02e-04 | 48 | 54 | 3 | CID000032281 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 5.00e-11 | 5 | 54 | 4 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 3.49e-10 | 7 | 54 | 4 | DOID:0060870 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 9.89e-09 | 14 | 54 | 4 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | osteoporosis (biomarker_via_orthology) | 7.15e-08 | 22 | 54 | 4 | DOID:11476 (biomarker_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 2.30e-07 | 29 | 54 | 4 | EFO_0008009 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 7.86e-07 | 39 | 54 | 4 | DOID:9744 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 7.45e-06 | 147 | 54 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | visceral adipose tissue measurement, body mass index | 1.99e-05 | 87 | 54 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | Russell-Silver syndrome | 1.47e-04 | 10 | 54 | 2 | C0175693 | |
| Disease | Primary microcephaly | 7.42e-04 | 22 | 54 | 2 | C0431350 | |
| Disease | neutrophil count, basophil count | 7.59e-04 | 224 | 54 | 4 | EFO_0004833, EFO_0005090 | |
| Disease | aspartate aminotransferase measurement | 1.25e-03 | 904 | 54 | 7 | EFO_0004736 | |
| Disease | Abnormality of refraction | 1.40e-03 | 673 | 54 | 6 | HP_0000539 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 2.58e-03 | 41 | 54 | 2 | DOID:10584 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWLLLVTLCLTEELA | 6 | Q14031 | |
| QLESLLQLWLTLSLN | 2656 | Q9NR09 | |
| RVLEALWELLLQAIL | 916 | O94812 | |
| ELKLLLLLLWLAASC | 741 | Q8NFM4 | |
| LLARLSLLTEQDLWT | 506 | Q5VTE6 | |
| IILTLLWESSENLLT | 1376 | Q9P1Z9 | |
| LRLLAAICLLLLTWV | 161 | Q9UHI5 | |
| LRTLARCLILWDDIL | 1406 | Q9H1A4 | |
| SWLCVLLLSSLLLLL | 66 | Q9BY79 | |
| SWRLLLLLLLLAAWK | 11 | Q9Y5H6 | |
| LLLLLSEALALTQTW | 6 | P13747 | |
| ARWHLTLLLVLEDRL | 436 | Q9NSY0 | |
| LRLCELWLLLLGSSL | 26 | Q4G1C9 | |
| LDRLWLETLLCLIGE | 151 | A6NMX2 | |
| RYWRTLVLLLLVLLT | 1756 | A9Z1Z3 | |
| LLRISLLLIESWLEP | 101 | P0DML3 | |
| TWALLLALALLLLLT | 6 | Q96SQ9 | |
| SAELSWLDLQLLEIL | 231 | Q6PIU1 | |
| LLLWLALLLSIQRRL | 531 | Q8IWD5 | |
| LGLESSLTLRRLLVW | 356 | Q96CW5 | |
| ELSLLQNLRTLWIEA | 116 | Q5BKY1 | |
| LLREEVILERLLTWQ | 396 | A6NGR9 | |
| AIWLLLSQLLRESLA | 11 | Q14641 | |
| FEDLWLITNELILRL | 606 | Q3SYG4 | |
| QCLLLSLLLLAAWEV | 11 | Q9Y5I2 | |
| LLLLLLLLLVSWASR | 11 | P10619 | |
| SRRLLLLLLLLAAWE | 11 | Q9UN74 | |
| ESLVLLRRLLAWDLD | 246 | Q96A11 | |
| LTLWLLSLLKLLNVR | 21 | Q9P109 | |
| LLRISLLLIESWLEP | 101 | P0DML2 | |
| TLRLSELDQLLNTLW | 246 | Q504Y0 | |
| SQRLLLSLLLLAAWE | 11 | Q9UN75 | |
| LEWLRRLSLELLKDS | 1281 | P42345 | |
| LQLRAELEALTDLWL | 411 | O00167 | |
| SSLELLNWILELLLR | 1161 | Q86VV8 | |
| ELSLDRLRTLLQLKW | 1186 | O95602 | |
| SWRALRLLEESLLSL | 736 | Q6ZMZ3 | |
| FDTLRLWLIILLCAL | 311 | Q8NDZ6 | |
| SLLWQREAITLSDLL | 221 | Q53T94 | |
| LQQLLLLLLENIREW | 471 | Q8IXR5 | |
| LRLALLILLTFILCW | 176 | Q96P88 | |
| LASLLLLLLLRLLWC | 11 | P61647 | |
| VLLLLADWVLLRTAL | 26 | Q03518 | |
| LRLLLWLEQNLERVL | 156 | Q14028 | |
| LLRISLLLIQSWLEP | 101 | P01242 | |
| ATKLVLILDDLLWVL | 231 | A0JNW5 | |
| LILDDLLWVLTDSQL | 236 | A0JNW5 | |
| EFLIWETALLLFLLR | 646 | Q9UMS5 | |
| KSLLLLEQREIWLLV | 661 | Q14159 | |
| LAQNTSWLLLLLLSL | 136 | P04216 | |
| SWLLLLLLSLSLLQA | 141 | P04216 | |
| TLLLILLRQWKRELG | 1161 | Q5SRE5 | |
| LLRISLLLIQSWLEP | 101 | P01241 | |
| LWLLLLLLPRTRADE | 16 | Q9HD45 | |
| WLQLQEADLSALRLL | 101 | Q6UX68 | |
| LATDQLLLLWDRILG | 456 | Q8N5T2 | |
| SRWEQVAALLLLLLL | 11 | Q8TEU8 |